Over-expression of Hepsin is associated with poor prognosis in epithelial ovarian cancer

XIA Bairong,YIN Mingzhu,GE Tingting,LU Beiyan,LOU Ge
DOI: https://doi.org/10.3969/j.issn.1672-1861.2013.02.013
2013-01-01
Abstract:Objective The purpose of this study was to determine whether Hepsin over-expression is associated with the prognosis in patients with epithelial ovarian carcinoma. Methods Hepsin expression was evaluated in 12 normal ovary, 18 benign ovarian tumor and 49 ovarian carcinomas specimens by Westem blotting; Hepsin expression was detected in 188 ovarian carcinomas specimens by using immunohistochemistry. The follow-up time was (71.4±0.5) months. All the possible risk factors that may influence the progression-free survival time(PFS) and overall survival time(OS) was analyzed. Results Western blotting analysis showed that Hepsin was under-expressed in 12 normal ovary and 18 benign ovarian tumor and over-expressed in 36 ovarian cancer (36/49, 73.5%). IHC analysis demonstrated that Hepsin was overexpressed in 122 epithelial ovarian carcinoma(122/188, 68.1%). The five-year overall survival (OS) rates for patients with high Hepsin expression and low Hepsin expression were 24.0% and 91.8% (hazard ratio: 20.335, 95% CI: 6.011~68.790,P<0.0001). The five-year progression-free survival (PFS) rate was 20.8% for patients in the high-expression group and 86.8% for patients in the low expression group(hazard ratio:15.604, 95% CI: 5.779~42.133, P<0.0001).Conclusions Hepsin over-expression is a factor in epithelial ovarian carcinoma prognosis , and it may be an important potential biomarker.
What problem does this paper attempt to address?